Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/4D7FA7ADDEFCBE857A5A00EFCE091FFAB9683690378432169E47125737DB85A30F5A7E4554559139377B2FC49ECEC18Ahttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/4D7FA7ADDEFCBE857A5A00EFCE091FFAB9683690378432169E47125737DB85A30F5A7E4554559139377B2FC49ECEC18Ahttp://www.w3.org/2000/01/rdf-schema#comment"In patients with CYP2C9*2 and CYP2C9*3 the clearance of warfarin and its dose were lower while the episodes of excessive hypocoagulation and hemorrhage associated with warfarin were more frequent than in patients without these allelic variants; Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"xsd:string
http://purl.uniprot.org/uniprot/#_151751547975F55DE54DC6D92B8D74D384896BA136F23E986F0CB47EE31A715E5847677CE22239BAAC27581678C6DF18http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/4D7FA7ADDEFCBE857A5A00EFCE091FFAB9683690378432169E47125737DB85A30F5A7E4554559139377B2FC49ECEC18A
http://purl.uniprot.org/uniprot/P11712http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/4D7FA7ADDEFCBE857A5A00EFCE091FFAB9683690378432169E47125737DB85A30F5A7E4554559139377B2FC49ECEC18A
http://purl.uniprot.org/uniprot/#_P11712-mappedCitation-17419358http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/4D7FA7ADDEFCBE857A5A00EFCE091FFAB9683690378432169E47125737DB85A30F5A7E4554559139377B2FC49ECEC18A